T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Thermo Fisher Scientific
TMO
$224B
| $2.99B | 0.62% |
22,277,486
-1,049,584
| -4% | -$135M |
|
27
Intuitive Surgical
ISRG
$142B
| $2.91B | 0.6% |
51,880,599
+169,299
| +0.3% | +$9.58M |
|
28
Salesforce
CRM
$162B
| $2.8B | 0.58% |
41,959,848
-198,011
| -0.5% | -$12.3M |
|
|
FISV
29
Fiserv Inc
FISV
$28B
| $2.69B | 0.56% |
67,747,678
+935,296
| +1% | +$35.7M |
|
30
Roper Technologies
ROP
$39.5B
| $2.64B | 0.54% |
15,332,237
+238,111
| +2% | +$38.6M |
|
31
AutoZone
AZO
$49.7B
| $2.63B | 0.54% |
3,860,570
-64,483
| -2% | -$40.5M |
|
32
Alibaba
BABA
$306B
| $2.49B | 0.51% |
29,866,391
+7,518,287
| +34% | +$679M |
|
33
Wells Fargo
WFC
$264B
| $2.48B | 0.51% |
45,557,653
-3,068,225
| -6% | -$166M |
|
|
PCYC
34
DELISTED
PHARMACYCLICS INC
PCYC
| $2.46B | 0.51% |
9,599,467
-287,017
| -3% | -$55.4M |
|
35
American Tower
AMT
$79B
| $2.4B | 0.5% |
25,533,067
-519,315
| -2% | -$50.5M |
|
36
ExxonMobil
XOM
$657B
| $2.37B | 0.49% |
27,861,507
-1,576,885
| -5% | -$140M |
|
37
Walt Disney
DIS
$179B
| $2.36B | 0.49% |
22,539,317
+1,327,864
| +6% | +$134M |
|
|
RHT
38
DELISTED
Red Hat Inc
RHT
| $2.27B | 0.47% |
30,012,323
-1,150,440
| -4% | -$77.9M |
|
|
PCP
39
DELISTED
PRECISION CASTPARTS CORP
PCP
| $2.27B | 0.47% |
10,794,226
-1,103,480
| -9% | -$234M |
|
40
Bank of America
BAC
$448B
| $2.26B | 0.47% |
147,028,518
+3,535,915
| +2% | +$56.8M |
|
41
Merck
MRK
$322B
| $2.25B | 0.47% |
41,110,919
-2,882,890
| -7% | -$163M |
|
42
Starbucks
SBUX
$122B
| $2.24B | 0.46% |
47,321,508
-8,305,732
| -15% | -$373M |
|
43
Vipshop
VIPS
$7.2B
| $2.23B | 0.46% |
75,913,214
+2,931,279
| +4% | +$71.1M |
|
44
Microsoft
MSFT
$3.74T
| $2.22B | 0.46% |
54,636,523
+4,687,778
| +9% | +$204M |
|
45
State Street
STT
$51.4B
| $2.19B | 0.45% |
29,817,195
-6,173,963
| -17% | -$462M |
|
46
Netflix
NFLX
$311B
| $2.18B | 0.45% |
366,780,400
+19,414,850
| +6% | +$118M |
|
|
AMTD
47
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.15B | 0.44% |
57,640,834
-11,979,351
| -17% | -$426M |
|
48
Sherwin-Williams
SHW
$88.5B
| $2.14B | 0.44% |
22,525,560
-6,501,390
| -22% | -$606M |
|
49
Incyte
INCY
$24.5B
| $2.05B | 0.42% |
22,409,960
+2,257,601
| +11% | +$187M |
|
50
CarMax
KMX
$8.26B
| $2.02B | 0.42% |
29,313,618
-1,751,625
| -6% | -$114M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.